Start / NVIDIA AI Podcast / How bristol myers squibb is accelerating drug development with ai ep 264

NVIDIA AI Podcast

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

32 min • 9 juli 2025

Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.

Senaste avsnitt

How Bristol Myers Squibb Is Accelerating Drug Development With AI - Ep. 264

9 juli | 32 min

Alembic and the Future of AI in Marketing - Ep. 263

2 juli | 40 min

Hippocratic AI's Munjal Shah on How AI Agents Are Expanding Healthcare Capacity - Ep. 262

25 juni | 22 min

CVS Health and Aible are Delivering Enterprise AI with Rapid Prototyping, Agents, and Reasoning Models - Ep. 261

18 juni | 40 min

NVIDIA’s Marco Pavone on AI Simulation, Safety, and the Road to Autonomous Vehicles - Ep. 260

11 juni | 36 min
Vad är en podd?

En liten tjänst av I'm With Friends. Finns även på engelska.

Podcastbild

00:00 -00:00
00:00 -00:00